株式会社極東書店トップ > 商品一覧 > Health Technology Assessment, Courts and the Right to Healthcare.
商品詳細
Health Technology Assessment, Courts and the Right to Healthcare.
・ISBN 978-1-138-55475-7 2022 hard GB£ 171.99
¥54,486.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
・ISBN 978-1-032-18491-3 2023 paper GB£ 46.99
¥14,886.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 978-1-315-14916-5
| 著者・編者 | Wang, Daniel Wei Liang, |
|---|---|
| 出版社 | (Routledge, UK) |
| 出版年月 | 2022.01 |
| ページ数 | 202 pp. |
| 言語 | ENG |
| ニュース番号 | <667-563 667-819> |
解説
Both developing and developed countries face an increasing mismatch between what patients expect to receive from healthcare and what the public healthcare systems can afford to provide. Where there has been a growing recognition of the entitlement to receive healthcare, the frustrated expectations with regards to the level of provision has led to lawsuits challenging the denial of funding for health treatments by public health systems.
This book analyses the impact of courts and litigation on the way health systems set priorities and make rationing decisions. In particular, it focuses on how the judicial protection of the right to healthcare can impact the institutionalization, functioning and centrality of Health Technology Assessment (HTA) for decisions about the funding of treatment. Based on the case study of three jurisdictions - Brazil, Colombia, and England - it shows that courts can be a key driver for the institutionalization of HTA. These case studies show the paradoxes of judicial control, which can promote accountability and impair it, demand administrative competence and undermine bureaucratic capacities. The case studies offer a nuanced and evidence-informed understanding of these paradoxes in the context of health care by showing how the judicial control of priority-setting decisions in health care can be used to require and control an explicit scheme for health technology assessment, but can also limit and circumvent it.
It will be essential for those researching Medical Law and Healthcare Policy, Human Rights Law, and Social Rights.